drugset / Trial / NCT00693004
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
Treatment
Summary
A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 monotherapy in subjects with Alzheimer's disease. The study consists of a 3-month double-blind treatment period and an optional 3-month extension period.
Timeline
- Start
- 2008-05
- Primary completion
- 2010-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | — | — |
| Subject | PRX-03140 | Small molecule | — | — |